# A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours

> **NCT05717348** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Elpiscience (Suzhou) Biopharma, Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Solid Tumor
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** ES014

## Key facts

- **NCT ID:** NCT05717348
- **Lead sponsor:** Elpiscience (Suzhou) Biopharma, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-24
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05717348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05717348, "A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05717348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*